These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34736903)

  • 41. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients.
    Björkman M; Sorva A; Risteli J; Tilvis R
    Age Ageing; 2008 Jan; 37(1):25-31. PubMed ID: 17965037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do low preoperative vitamin D levels reduce the accuracy of quick parathyroid hormone in predicting postthyroidectomy hypocalcemia?
    Lang BH; Wong KP; Cowling BJ; Fong YK; Chan DK; Hung GK
    Ann Surg Oncol; 2013 Mar; 20(3):739-45. PubMed ID: 22968355
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Dasgupta A; Khalil S; Paddock T; Wahed A
    Ann Clin Lab Sci; 2022 Jan; 52(1):161-163. PubMed ID: 35181630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erroneous thyroid diagnosis due to over-the-counter biotin.
    Charles S; Agrawal N; Blum M
    Nutrition; 2019 Jan; 57():257-258. PubMed ID: 30199718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of four different PTH methods on the classification of chronic kidney disease patients according to the new KDIGO guideline.
    Ten BE; Van Veen MC; Vervloet MG; Fischer JC; Koopman MG; Van Dam B
    Clin Lab; 2012; 58(7-8):719-24. PubMed ID: 22997972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
    Boudou P; Ibrahim F; Cormier C; Sarfati E; Souberbielle JC
    J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of new Beckman Coulter 25(OH) Vitamin D assay and potential improvement of clinical interpretation.
    Madenci ÖÇ; Orçun A; Yildiz Z; Sirmali R; Tunçbilek N; Yücel N; Temel Y; Bölük A
    Biochem Med (Zagreb); 2017 Jun; 27(2):332-341. PubMed ID: 28694724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism.
    Ozbey N; Erbil Y; Ademoğlu E; Ozarmağan S; Barbaros U; Bozbora A
    World J Surg; 2006 Mar; 30(3):321-6. PubMed ID: 16467981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selected performance characteristics of the Roche Elecsys testosterone II assay on the Modular analytics E 170 analyzer.
    Owen WE; Rawlins ML; Roberts WL
    Clin Chim Acta; 2010 Aug; 411(15-16):1073-9. PubMed ID: 20385114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of biotin interference in thyroid function tests.
    Zhang Y; Wang R; Dong Y; Huang G; Ji B; Wang Q
    Medicine (Baltimore); 2020 Feb; 99(9):e19232. PubMed ID: 32118725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison between two different automated total 25-hydroxyvitamin D immunoassay methods using liquid chromatography-tandem mass spectrometry.
    Kocak FE; Ozturk B; Isiklar OO; Genc O; Unlu A; Altuntas I
    Biochem Med (Zagreb); 2015; 25(3):430-8. PubMed ID: 26526462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance characteristics of six automated 25-hydroxyvitamin D assays: Mind your 3s and 2s.
    Wyness SP; Straseski JA
    Clin Biochem; 2015 Nov; 48(16-17):1089-96. PubMed ID: 26272200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitigating biotin interference in two Roche immunoassays by premixing biotinylated capturing molecules with streptavidin coated beads.
    Yang J; Wiencek JR
    Clin Chim Acta; 2020 Jun; 505():130-135. PubMed ID: 32084383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endogenous anti-streptavidin antibodies causing erroneous laboratory results more common than anticipated.
    Dahll LK; Haave EM; Dahl SR; Aas FE; Thorsby PM
    Scand J Clin Lab Invest; 2021 Apr; 81(2):92-103. PubMed ID: 33502256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
    Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
    Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly.
    Arabi A; Baddoura R; El-Rassi R; El-Hajj Fuleihan G
    Osteoporos Int; 2012 Mar; 23(3):971-80. PubMed ID: 21656018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parathyroid hormone as a mortality predictor in frail aged inpatients.
    Bjorkman M; Sorva A; Tilvis R
    Gerontology; 2009; 55(6):601-6. PubMed ID: 19752529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages.
    Patel S; Barron JL; Mirzazedeh M; Gallagher H; Hyer S; Cantor T; Fraser WD
    J Bone Miner Metab; 2011 Jan; 29(1):71-9. PubMed ID: 20521154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
    Monge M; Jean G; Bacri JL; Lemaitre V; Masy E; Joly D; Souberbielle JC
    Clin Chem Lab Med; 2009; 47(3):362-6. PubMed ID: 19199835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin D and intact PTH status in patients with hip fracture.
    Sakuma M; Endo N; Oinuma T; Hayami T; Endo E; Yazawa T; Watanabe K; Watanabe S
    Osteoporos Int; 2006; 17(11):1608-14. PubMed ID: 16874442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.